von Prof. Dr. Heiner Wedemeyer et al. (10/2025) The first human xenogeneic liver transplantation – A landmark event, but what does it mean for hepatology? ► Mehr erfahren Führende internationale Tagung [...] der Hepatologie. ► Mehr erfahren Dankeschön an Grüne Damen und Herren (03/2025) Klinik- und Institutsleitungen verabschieden sich mit besonderer Spende von MHH-Präsident ► Mehr erfahren Gastro-Geplauder [...] Hepatitis D (03/2024) Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta ► Mehr erfahren Mögliche Tumormarker
T; Feasibility of Using a Novel Drop-In Gamma Probe for 99m Tc-PSMA-I&S-Guided Lymph Node Detection During Robot-Assisted Radical Prostatectomy for Primary Prostate Cancer. 2024, Clin. Nucl. Med. 49, 948–952 [...] n. Hannover 2015 Szermerski B, Bruchmann I, Behrens R, Geworski L; Dose rate constants for the quantity Hp(3) for frequently used radionuclides in nuclear medicine. Zeitschrift für Medizinische Physik [...] flow with I-123-hippurate in liver transplanted children - evidence for its impairment and validation of a simplified procedure for its determination provided by Sapirstein's method. Tagung der Europäischen
2016; S. 222-252. Robert Koch-Institut, Walter U . Ausblicke. Gespräche mit Experten. In: Robert Koch-Institut. Bericht zum Krebsgeschehen in Deutschland 2016. Robert Koch-Institut: Berlin, 2016; S. 257-269 [...] Prof. Dr. phil. Ulla Walter Institutsdirektorin Leiterin des Forschungsschwerpunkts Prävention und Rehabilitation Tel.: +49 511 532 - 4455 Fax: +49 511 532 - 5376 E-Mail: Walter.Ulla @ mh-hannover.de [...] Capacity Building Qualitätsentwicklung Wissenschaftliche Tätigkeit (Auswahl) seit 2009 Direktorin des Instituts für Epidemiologie, Sozialmedizin und Gesundheitssystemforschung der Medizinischen Hochschule Hannover
working group (2022). Dual guidance structure for evaluation of patients with unclear diagnosis in centers for rare diseases (ZSE-DUO): study protocol for a controlled multi-center cohort study. Orphanet [...] Leone C, Santic-Milicevic M, Sermeus W. Ungureanu M, for the EUPHA section Health Workforce Research. A call for action to establish a research agenda for building a future health workforce in Europe. Health [...] (2018). Public, medical professionals’ and patients’ preferences for the allocation of donor organs for transplantation: study protocol for discrete choice experiments. BMJ Open 2018;8:e026040. doi:10.1
in Network Meta-Analysis: Comparative Performance of Methods for Sparse Safety Outcomes . In: ISPOR Europe 2024 (The International Society for Pharmacoeconomics and Outcomes Research), 17-20/11/2024, Barcelona [...] Mueller AN, Pehlke-Milde J . Development and validation of a tool for advising primiparous women during early labour: study protocol for the GebStart Study. BMJ Open. 2022 Jun 27;12(6): e062869. https://doi [...] on animal research with implications for meta-analyses. Res Synth Methods 2021;12(6):701-710. Welsh J , Gross MM , Hanson C, Hounkpatin H, Moller AB. Protocol for a scoping review to identify and map
Agich G, Neitzke G, McCarthy M, Molewijk B, de Snoo-Trimp J. &Eijkholt M (2023): Europe: It Is Time for Patient Participation in Ethics Interventions! Journal of Hospital Ethics 9(2): 14 Selter F, Persson [...] Neitzke G (2023): End-of-life decisions: A focus group study with German health professionals from human and veterinary medicine. Front Vet Sci 10:1044561. DOI: 10.3389/fvets.2023.1044561 Strech D, Neitzke [...] Tom go? An empirical study on intuitions regarding end-of-life decisions in companion animals and humans. Animals 12: 2494. DOI: 10.3390/ani12192494 Neitzke G, Simon A (2022): Clinical ethics consultation
Telefax: +49 511-532-5376 E-Mail: Roeding.Dominik @ mh-hannover.de Lehre Epidemiologie (Studiengang Humanmedizin) Prävention und Gesundheitsförderung, Statistik 1, Statistik 2 und Soziologische Grundlagen der [...] 32(3): 181–185 Mathes T, Röding D , Stegbauer C, Laxy M, Pieper D (2024). Interrupted Time Series for Assessing the Causality of Intervention Effects. Part 35 of a Series on Evaluating Scientific Publications [...] doi.org/10.1515/pubhef-2024-0088 Birgel V, Decker D, Röding D & Walter U (2023). Community capacity for prevention and health promotion: a scoping review on underlying domains and assessment methods. Systematic
Binder S, Klug C, Schippert C, Ebert AD and Halis G (2022). Cross‑sectional study for derivation of a cut‑off value for identification of an early versus delayed diagnosis of endometriosis based on analytical [...] in I, for the QS Endo Working Group of the Endometriosis Research Foundation (SEF) (2020). QS Endo Real – A Study by the German Endometriosis Research Foundation (SEF) on the Reality of Care for Patients [...] I, Kluge K, Mau W. Short- and long-term effects of intensive training and motivational programme for continued physical activity in patients with inflammatory rheumatic diseases. Eur J Phys Rehabil Med
Magni (Hg.) Integration of omics approaches and systems biology for clinical applications integration of Omics Approaches and Systems Biology for Clinical Applications, Weinheim: Wiley, 2018, 13-25 Lohff, B [...] Ludwig's (1847) and Pavel Petrovich Einbrodt's (1860) physiological research and its implications for modern cardiovascular science: Translator's notes relating to the English translation of two seminal [...] Kommentar zu Benno Müller-Hill " Erinnerung ist Voraussetzung aller Ethik: Der Fall der Deutschen Humangenetik. In: Weber, M., Hoyningen-Huene, P.: Ethische Probleme in den Biowissenschaften. Heidelberg 2001
Hannover Prof. Dr. Birgit Babitsch, New Public Health, FB 8 - Humanwissenschaften, Universität Osnabrück Prof. Dr. Christine S. Falk, Institut für Transplantationsimmunologie, Medizinische Hochschule Hannover [...] en, internistischen, immunologischen und soziologischen Blickwinkel heraus erprobt. Beteiligte Institute: Prof. Dr. Dr. Anette Melk, Klinik für Pädiatrische Nieren-, Leber- und Stoffwechselerkrankungen [...] Grabow J, Sperlich S, Koch-Gießelmann H, Jaunzeme J, Geyer S (2013). Return to work after treatment for primary breast cancer over a six-year period: Results from a prospective study comparing patients with